These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36296203)

  • 21. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for
    Hong JY; Kim A; Park SY; Cho SN; Dockrell HM; Hur YG
    Front Cell Infect Microbiol; 2021; 11():599386. PubMed ID: 33869073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.
    Tebruegge M; Ritz N; Donath S; Dutta B; Forbes B; Clifford V; Zufferey C; De Rose R; Robins-Browne RM; Hanekom W; Graham SM; Connell T; Curtis N
    Front Immunol; 2019; 10():431. PubMed ID: 31024518
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
    Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
    EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
    Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
    PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays.
    Dirix V; Dauby N; Hites M; Watelet E; Van Praet A; Godefroid A; Petit E; Singh M; Locht C; Mascart F; Corbière V
    J Clin Microbiol; 2022 May; 60(5):e0244321. PubMed ID: 35430897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?
    Whittaker E; Gordon A; Kampmann B
    PLoS One; 2008; 3(12):e3901. PubMed ID: 19065267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.
    Wyndham-Thomas C; Corbière V; Dirix V; Smits K; Domont F; Libin M; Loyens M; Locht C; Mascart F
    Clin Vaccine Immunol; 2014 Mar; 21(3):321-8. PubMed ID: 24391135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Close contact interferon-gamma response to the new PstS1
    de Araujo LS; de Bárbara Moreira da Silva Lins N; Leung JA; Mello FC; Saad MH
    BMC Res Notes; 2017 Jan; 10(1):59. PubMed ID: 28114976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis.
    Kim JY; Kang YA; Park JH; Cha HH; Jeon NY; Lee SW; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Clin Microbiol Infect; 2020 Jul; 26(7):928-934. PubMed ID: 31730906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.